>
Organization
Moerae Matrix, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Moerae Matrix, Inc.

... Limited, Kolltan Pharmaceuticals, Inc., Kyorin Pharmaceutical Co., Ltd., Lung Therapeutics Inc, Moerae Matrix, Inc., MorphoSys AG, Novartis AG, Nuevolution AB, Pharmaxis Limited, Promedior, Inc., ProMetic ...
... Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial ...
... Moerae Matrix, a clinical stage biotechnology company focused on developing novel therapeutics that ...
... Moerae Matrix, a clinical stage biotechnology company focused on developing novel therapeutics that ...
... LTT Bio-Pharma Co., Ltd., MedImmune, LLC, Mesoblast Limited, miRagen Therapeutics, Inc., Moerae Matrix, Inc., MSM Protein Technologies, Inc., NicOx S.A., Pacific Therapeutics Ltd., Pharmaxis Limited, ...
... a First-in-Class Inhibitor of MK2, for Treatment of Idiopathic Pulmonary Fibrosis . Moerae Matrix Initiates Phase 1 Clinical Trial of MMI-0100, a First-in-Class Inhibitor of ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/moerae-matrix-inc-o1448413
  • https://relationshipscience.com/News/moerae-matrix-inc-o1448413
Subscribe now for full coverage on Moerae Matrix, Inc.
Start My Free Trial